VC Catalog · venture ecosystem research library
VC Catalog home Beta

VC firm

Polaris Partners

Kingmaker TierBased on the data VC Catalog holds.

Kingmaker Tier: 98 out of 100

Also known as LS Polaris Innovation Fund, LS Polaris Innovation Fund Management, L.L.C., LS Polaris Innovation Fund, L.P.; Polaris Innovation Fund II, L.P., North Star Venture Management 2026, L.L.C. (fka North Star Venture Management 2010, L.L.C.), North Star Venture Management Legacy, L.L.C., North Star Ventures SG Pte. Ltd., Polaris, Polaris Entrepreneurs

  • Biotech & therapeutics
  • Care delivery & digital health
  • Health IT
  • Medical devices & diagnostics
  • Mental health & wellness
  • Women's & family health
  • Multi stage
  • Seed
  • VC
  • B2B
Investor type
VC
Investing status
Activeas of 2026-09-28Source (opens in a new tab)
Headquarters
Boston, Massachusetts, United States
Assets under management
$4.2BForm ADV private fund GAV, as of 2026-07-10Source (opens in a new tab)
Latest fund size
$355MSEC amount sold, as of 2023-04-21Source (opens in a new tab)
Funds
21
Legal name
POLARIS GROWTH MANAGEMENT, LLC
Claim, correct or request removal

Record updated 29 September 2026

About

Polaris Partners is a Boston-founded (1996) investment firm with nearly 30 years of experience backing transformational healthcare, biotech, and life-sciences companies, and also invests in technology through affiliate funds. Across its history it reports 400+ companies funded, 100+ exits, 50+ IPOs and 60+ therapies to market. Distinct affiliate funds serve different strategies: the core Polaris (Main) Funds do early/venture-stage healthcare and life-sciences investing; the Polaris Growth Fund does levered recapitalizations of software/tech-enabled-services companies; and the Polaris Innovation Fund accelerates commercial/therapeutic potential of early-stage academic research. Offices are in Boston, New York, San Francisco, and Singapore.

Investment approach

Thesis
Great companies are built upon a foundation of real partnership.Source (opens in a new tab)
Investing status notes
Home page 'all-news' feed cites 2026 portfolio news (e.g. FDA approval, Sept 2026 acquisition), and Important Disclosures states figures 'as of Q4 2026'.

Funds

Polaris Partners XI, L.P.
$187MVintage 2025, Main fund, SEC amount sold
Polaris Partners X, L.P.
$355MVintage 2022, Main fund, SEC amount sold
Polaris Healthcare Technology Opportunities Fund, L.P.
Vintage 2020Main fund
Polaris Partners IX, L.P.
Vintage 2019Main fund
Polaris Entrepreneurs' Fund VIII, L.P.
$14.5MVintage 2017, Main fund, SEC amount sold
Polaris Partners VII, L.P.
$436MVintage 2014, Main fund, SEC amount sold
Polaris Entrepreneurs' Fund VII, L.P.
$26MVintage 2014, Main fund, SEC amount sold
Polaris Venture Partners VI, L.P.
$234MVintage 2010, Main fund, SEC amount sold
POLARIS VENTURE PARTNERS ENTREPRENEURS FUND IV, L.P.
Main fund
POLARIS VENTURE PARTNERS V, L.P.
Main fund
POLARIS VENTURE PARTNERS IV, L.P.
Main fund
PGF SPV-A, L.L.C.
SPV
More funds
9 more recorded

SEC registration

Registered adviser
POLARIS GROWTH MANAGEMENT, LLC
SEC file number
801-113566
Registration
SEC registered
Regulatory AUM
$4.2Bas of 2026-07-10
Private funds reported
18
Principal office
BOSTON, MA, United States
SEC CIK
1493463, 1611189, 1615991

Locations

Office
Boston
Office
New York
Office
San Francisco
Office
Singapore
Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy